Redx Pharma
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Redx Pharma's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 78% to $4,202,000. Profit margin reached -789%. Total operating expenses were $35,182,000.

Profit Margin

Redx Pharma Plc (LSE:REDX.L): Profit margin
2014 0 -3.35M
2015 0 -8.17M
2016 0 -15.52M
2017 30.47M 1.52M 5.01%
2018 129K -8.84M -6856.59%
2019 3.13M -4.31M -137.91%
2020 5.68M -9.21M -162.06%
2021 10.03M -21.57M -215.01%
2022 18.69M -18.00M -96.33%
2023 4.20M -33.15M -789.05%

REDX.L Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
4.20M18.69M10.03M5.68M3.13M129K30.47M000
Cost of revenue
960K000350K00262K00
Gross profit
3.24M18.69M10.03M5.68M2.78M129K30.47M-262K00
Operating exp.
Research and development
29.11M28.56M24.44M9.94M6.16M5.73M8.16M8.06M5.09M2.89M
Selling and marketing
0000000000
Total operating expenses
35.18M37.25M29.78M13.95M9.97M9.33M17.42M14.39M9.43M4.01M
Operating income
-33.82M-16.26M-19.74M-8.27M-7.19M-10.16M1.97M-14.94M-9.43M-4.01M
Other income (expenses), net
1.03M-1.53M-1.69M-1.31M858K-947K-10.44M-1.01M606K-249K
Income before tax
-32.78M-17.80M-21.44M-9.16M-6.33M-10.14M1.64M-15.40M-8.82M-4.26M
Income tax expense
368K201K133K45K-2.01M-1.30M118K114K-650K-910K
Net income
-33.15M-18.00M-21.57M-9.21M-4.31M-8.84M1.52M-15.52M-8.17M-3.35M
Earnings per share
Basic EPS
-0.09-0.06-0.08-0.05-0.03-0.060.01-0.2-0.14-0.05
Diluted EPS
-0.09-0.06-0.08-0.05-0.03-0.060.01-0.2-0.14-0.05
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source